Associated Papers
Pathogenetic mechanisms of muscle-specific ribosomes in dilated cardiomyopathy.
Murphy MR et al.
Nature Cardiovascular Research, 2026
Pathogenetic mechanisms of muscle-specific ribosomes in dilated cardiomyopathy.
Murphy MR et al.
Biorxiv : the Preprint Server for Biology, 2025
Novel compound heterozygous variants in the RPL3L gene causing dilated cardiomyopathy type-2D: a case report and literature review.
Yang Q et al.
Bmc Medical Genomics, 2023
Compound Heterozygous Missense Variants in RPL3L Genes Associated with Severe Forms of Dilated Cardiomyopathy: A Case Report and Literature Review.
Das BB et al.
Children (basel, Switzerland), 2022
Further Evidence of Autosomal Recessive Inheritance of RPL3L Pathogenic Variants with Rapidly Progressive Neonatal Dilated Cardiomyopathy.
Nannapaneni H et al.
Journal of Cardiovascular Development and Disease, 2022
Bi-allelic missense disease-causing variants in RPL3L associate neonatal dilated cardiomyopathy with muscle-specific ribosome biogenesis.
Ganapathi M et al.
Human Genetics, 2020
The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma.
Matsushita H et al.
Oncoimmunology, 0
28920005 (PubMed )
Supplement: supplement_1.zip › KONI_A_1338996_s03.xlsx › Supplementary_Table_S2
Select a paper to view details